2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Wednesday, September 25, 2019

1:15pm-2:45pm: Longitudinal Change of Substantia Nigra Hyperechogenicity in Parkinson’s Disease Cohort

T. Toomsoo, I. Rubanovits, R. Kerner, T. Asser, M. Vähi, P. Taba (Tallinn, Estonia)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Longitudinal Cortical Changes Associated with Apathy in Parkinson’s Disease

E. Canu, F. Agosta, F. Imperiale, T. Stojković, I. Stankovic, S. Basaia, A. Fontana, V. Markovic, I. Petrović, E. Stefanova, V. Kostic, M. Filippi (Milan, Italy)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: Low and high beta band activity in the primary sensorimotor cortex is diminished by ipsilateral subthalamic stimulation in Parkinsonian patients

G. Tamas, A. Kelemen, B. Javor-Duray, M. Palotai, L. Halasz, L. Eross, G. Fekete, L. Bognar, G. Deuschl, M. Muthuraman (Budapest, Hungary)

Surgical Therapy · Les Muses Terrace, Level 3

1:15pm-2:45pm: Low doses of scopolamine exacerbates dementia among Drosophila with Parkinson’s disease pathophysiology

G. Chandran (Mysore, India)

Cognition and Cognitive Disorders · Agora 3 East, Level 3

1:15pm-2:45pm: Lymphocyte Senescence in Parkinson’s Disease

M. Jensen, K. Scott, M. Camacho, A. Kouli, R. Wijeyekoon, I. Solim, R. Barker, C. Williams-Gray (Cambridge, United Kingdom)

Physiology and Pathophysiology · Les Muses, Level 3

1:15pm-2:45pm: Maladaptive Nigrovagal Neuronal Plasticity Causes Ascending Alpha-Synucleinopathy in a Novel Environmental Toxin Based Rat Model of Parkinsonism

T. Subramanian, K. Le, S. Hojjatinia, K. Venkiteswaran, M. Subramanian, L. Anselmi, C. Bove, R. Travagli (Hershey, PA, USA)

Physiology and Pathophysiology · Les Muses, Level 3

1:15pm-2:45pm: Mandibular Advancement Device in Parkinson’s disease: an efficacious and usable device in a disabling disease

V. Cochen Decock, M. Castel, I. Bonafé (Montpellier, France)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: MCI reverters have a favorable cognitive prognosis and cortical integrity in Parkinson’s disease

SJ. Chung, Y-H. Park, YH. Sohn, J-M. Lee, PH. Lee (Seoul, Republic of Korea)

Cognition and Cognitive Disorders · Agora 3 East, Level 3

1:15pm-2:45pm: Measurement properties of the MDS-NMS Non-motor Fluctuations Subscale

MJ. Forjaz, A. Ayala, C. Rodriguez-Blazquez, A. Schrag, D. Weintraub, A. Rizos, KR. Chaudhuri, P. Martinez-Martin (Philadelphia, PA, USA)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: Measuring cognitive decline in PD-MCI patients with high level education: Do we have the appropriate tools?

L. Mentzer, A. Richardson, T. Nevo, S. Meyer, S. Rosenblum, N. Gemerman, S. Hassin-Baer, S. Israeli-Korn, T. Fay-Karmon, V. Livneh, G. Yahalom (Ramat-Gan, Israel)

Cognition and Cognitive Disorders · Agora 3 East, Level 3